Skip to content

A comparation of efficacy and mechanism on accelerated continuous and intermittent theta burst stimulation for the treatment in depressive adolescents

A comparation of efficacy and mechanism on accelerated continuous and intermittent theta burst stimulation for the treatment in depressive adolescents

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400082708
Enrollment
Unknown
Registered
2024-04-04
Start date
2024-04-05
Completion date
Unknown
Last updated
2025-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depressive adolescents

Interventions

a-cTBS group:Accelerated continuous TBS
a-iTBS group:Accelerated intermittent TBS

Sponsors

The Affiliated Kangning Hospital of Ningbo University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1.Meets the diagnostic criteria for depressive disorders of the ICD-10; 2.Age 12-18 years; 3.Right-handed; 4.Signed an informed consent form;

Exclusion criteria

Exclusion criteria: 1.Participants with severe physical, infectious and immune system disorders; 2.Participants with severe neurological disorders, mental retardation or organic brain disorders; 3.Pregnant or breastfeeding women; 4.Participants who received electroconvulsive therapy within the last 3 months; 5.Participants with the history of seizures; 6.Participants who assessed to be unsuitable for cTBS treatment and those unable to complete relevant indicator collection;

Design outcomes

Primary

MeasureTime frame
HAMD;Suicidal ideation;

Secondary

MeasureTime frame
Neuroelectrophysiology and brain imaging;HAMA;Neuroinflammatory factors and related immune factors;

Countries

China

Contacts

Public ContactXiaoli Liu

The Affiliated Kangning Hospital of Ningbo University

1206207800@qq.com+86 574 26302510

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026